The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Is the Complement Activation Product C3a a Proinflammatory Molecule? Re-evaluating the Evidence and the Myth
Abstract
The complement activation product C3a is often described as a proinflammatory mediator, alongside its downstream cousin, C5a. However, emerging studies show that C3a has several anti-inflammatory facets in vivo. For example, in the acute inflammatory response, C3a acts in direct opposition to C5a, through preventing the accumulation of neutrophils in inflamed tissues by independently regulating their mobilization. This acute, protective, and opposing activity of C3a to C5a is also illustrated in models of septicemia. In this article, we reinvestigate the discovery and original classification of C3a as a proinflammatory mediator and highlight the emerging studies demonstrating anti-inflammatory effects for C3a in the immune response. It is our hope that this review illuminates these apparently contradictory roles for C3a and challenges the general dogma surrounding C3a, which, historically, has ubiquitously been described as a proinflammatory mediator. In light of this, we urge investigators to use “inflammatory modulator” as the descriptor for C3a.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Generation of C5a in the absence of C3: a new complement activation pathway
Huber-Lang, M., Sarma, J. V., Zetoune, F. S., Rittirsch, D., Neff, T. A., McGuire, S. R., Lambris, J. D., Warner, R. L., Flierl, M. A., Hoesel, L. M., et al. (2006) · Nature Medicine · doi:10.1038/nm1419 · Cited by 975
The role of the anaphylatoxins in health and disease
Klos, A., Tenner, A. J., Johswich, K.-O., Ager, R. R., Reis, E. S., & Köhl, J. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.04.027 · Cited by 730 · cited 2×
“Tissue injury also directly activates the complement system, leading to the generation of the peptides C5a and C3a (31).”
BackgroundComplement and coagulation: strangers or partners in crime?
Markiewski, M. M., Nilsson, B., Nilsson Ekdahl, K., Mollnes, T. E., & Lambris, J. D. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.02.006 · Cited by 645
Liszewski, M. K., Kolev, M., Le Friec, G., Leung, M., Bertram, P. G., Fara, A. F., Subias, M., Pickering, M. C., Drouet, C., Meri, S., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.018 · Cited by 582
Strainic, M. G., Liu, J., Huang, D., An, F., Lalli, P. N., Muqim, N., Shapiro, V. S., Dubyak, G. R., Heeger, P. S., & Medof, M. E. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.001 · Cited by 580
Cellular signalling of the receptor for advanced glycation end products (RAGE)
Xie, J., Méndez, J. D., Méndez-Valenzuela, V., & Aguilar-Hernández, M. M. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.06.013 · Cited by 513
Cochrane, C. G., & Müller-Eberhard, H. J. (1968) · The Journal of Experimental Medicine · doi:10.1084/jem.127.2.371 · Cited by 461
Complement activation and inhibition: a delicate balance
Sjöberg, A. P., Trouw, L. A., & Blom, A. M. (2009) · Trends in Immunology · doi:10.1016/j.it.2008.11.003 · Cited by 364
Asgari, E., Le Friec, G., Yamamoto, H., Perucha, E., Sacks, S. S., Köhl, J., Cook, H. T., & Kemper, C. (2013) · Blood · doi:10.1182/blood-2013-05-502229 · Cited by 310
Strainic, M. G., Shevach, E. M., An, F., Lin, F., & Medof, M. E. (2013) · Nature Immunology · doi:10.1038/ni.2499 · Cited by 302
Daffern, P. J., Pfeifer, P. H., Ember, J. A., & Hugli, T. E. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.6.2119 · Cited by 281
Klos, A., Wende, E., Wareham, K. J., & Monk, P. N. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005223 · Cited by 264
Neutrophils—A Key Component of Ischemia-Reperfusion Injury
Schofield, Z. V., Woodruff, T. M., Halai, R., Wu, M. C.-L., & Cooper, M. A. (2013) · Shock · doi:10.1097/shk.0000000000000044 · Cited by 249
Self-citationMONSINJON, T., GASQUE, P., CHAN, P., ISCHENKO, A., BRADY, J. J., & FONTAINE, M. (2003) · The FASEB Journal · doi:10.1096/fj.02-0737com · Cited by 249
C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a
Chen, N.-J., Mirtsos, C., Suh, D., Lu, Y.-C., Lin, W.-J., McKerlie, C., Lee, T., Baribault, H., Tian, H., & Yeh, W.-C. (2007) · Nature · doi:10.1038/nature05559 · Cited by 243
C3a and C5a Promote Renal Ischemia-Reperfusion Injury
Peng, Q., Li, K., Smyth, L. A., Xing, G., Wang, N., Meader, L., Lu, B., Sacks, S. H., & Zhou, W. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011111072 · Cited by 222
Kwan, W.-H., van der Touw, W., Paz-Artal, E., Li, M. O., & Heeger, P. S. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20121525 · Cited by 215
A new biologic role for C3a and C3a desArg: regulation of TNF-α and IL-1 β synthesis
Takabayashi, T., Vannier, E., Clark, B. D., Margolis, N. H., Dinarello, C. A., Burke, J. F., & Gelfand, J. A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.9.3455 · Cited by 207
C5L2: a controversial receptor of complement anaphylatoxin, C5a
Li, R., Coulthard, L. G., Wu, M. C. L., Taylor, S. M., & Woodruff, T. M. (2013) · The FASEB Journal · doi:10.1096/fj.12-220509 · Cited by 206
Self-citationCOMPLEMENT AS A MEDIATOR OF INFLAMMATION
da Silva, W. D., & Lepow, I. H. (1967) · The Journal of Experimental Medicine · doi:10.1084/jem.125.5.921 · Cited by 192
Kildsgaard, J., Hollmann, T. J., Matthews, K. W., Bian, K., Murad, F., & Wetsel, R. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5406 · Cited by 188
C5L2 Is a Functional Receptor for Acylation-stimulating Protein
Kalant, D., MacLaren, R., Cui, W., Samanta, R., Monk, P. N., Laporte, S. A., & Cianflone, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m406921200 · Cited by 177
The Chemoattractant Receptor-like Protein C5L2 Binds the C3a des-Arg77/Acylation-stimulating Protein
Kalant, D., Cain, S. A., Maslowska, M., Sniderman, A. D., Cianflone, K., & Monk, P. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206169200 · Cited by 175
Shinjyo, N., Ståhlberg, A., Dragunow, M., Pekny, M., & Pekna, M. (2009) · Stem Cells · doi:10.1002/stem.225 · Cited by 171
The Human C3a Receptor Is Expressed on Neutrophils and Monocytes, but Not on B or T Lymphocytes
Martin, U., Bock, D., Arseniev, L., Tornetta, M. A., Ames, R. S., Bautsch, W., Köhl, J., Ganser, A., & Klos, A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.199 · Cited by 171
Elsner, J., Oppermann, M., Czech, W., & Kapp, A. (1994) · Blood · doi:10.1182/blood.v83.11.3324.3324 · Cited by 170
Drouin, S. M., Corry, D. B., Hollman, T. J., Kildsgaard, J., & Wetsel, R. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5926 · Cited by 167
Ischemia/reperfusion-induced feline intestinal dysfunction: Importance of granulocyte recruitment
Kubes, P., Hunter, J., & Granger, D. N. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90010-v · Cited by 166
Wu, M. C. L., Brennan, F. H., Lynch, J. P. L., Mantovani, S., Phipps, S., Wetsel, R. A., Ruitenberg, M. J., Taylor, S. M., & Woodruff, T. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218815110 · Cited by 165
Self-citationHuman anaphylatoxin (C3a) from the third component of complement. Primary structure.
Hugli, T. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40758-8 · Cited by 164
C3a Mediates Epithelial-to-Mesenchymal Transition in Proteinuric Nephropathy
Tang, Z., Lu, B., Hatch, E., Sacks, S. H., & Sheerin, N. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008040434 · Cited by 147
Banda, N. K., Hyatt, S., Antonioli, A. H., White, J. T., Glogowska, M. J., Takahashi, K., Merkel, T. J., Stahl, G. L., Mueller‐Ortiz, S. L., Wetsel, R. A., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102310 · Cited by 137
Fischer, W. H., & Hugli, T. E. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.9.4279 · Cited by 128
Regulation of IL-6 Synthesis in Human Peripheral Blood Mononuclear Cells by C3a and C3adesArg
Fischer, W. H., Jagels, M. A., & Hugli, T. E. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.1.453 · Cited by 123
Bao, L., Osawe, I., Haas, M., & Quigg, R. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1947 · Cited by 115
Bautsch, W., Hoymann, H.-G., Zhang, Q., Meier-Wiedenbach, I., Raschke, U., Ames, R. S., Sohns, B., Flemme, N., zu Vilsendorf, A. M., Grove, M., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5401 · Cited by 113
Boos, L. A., Campbell, I. L., Ames, R. S., Wetsel, R. A., & Barnum, S. R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.7.4708 · Cited by 102
Hannedouche, S., Beck, V., Leighton-Davies, J. R., Beibel, M., Roma, G., Oakeley, E. J., Lannoy, V. J., Bernard, J., Hamon, J., Barbieri, S., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.497214 · Cited by 96
The C3a receptor antagonist SB 290157 has agonist activity
Mathieu, M., Sawyer, N., Greig, G. M., Hamel, M., Kargman, S., Ducharme, Y., Lau, C. K., Friesen, R. W., O’Neill, G. P., Gervais, F. G., et al. (2005) · Immunology Letters · doi:10.1016/j.imlet.2005.03.003 · Cited by 94
Ruan, B. H., Li, X., Winkler, A. R., Cunningham, K. M., Kuai, J., Greco, R. M., Nocka, K. H., Fitz, L. J., Wright, J. F., Pittman, D. D., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000863 · Cited by 83
The anaphylatoxin C3a downregulates the Th2 response to epicutaneously introduced antigen
Kawamoto, S., Yalçindağ, A., Laouini, D., Brodeur, S. R., Bryce, P. J., Lu, B., Humbles, A. A., Oettgen, H. C., Gerard, C. J., & Geha, R. S. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19082 · Cited by 83
Two different transduction pathways are activated by C3a and C5a anaphylatoxins on astrocytes
Sayah, S., Jauneau, A.-C., Patte‐Mensah, C., Tonon, M., Vaudry, H., & Fontaine, M. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(03)00046-9 · Cited by 82
Functions of the complement components C3 and C5 during sepsis
Flierl, M. A., Rittirsch, D., Nadeau, B. A., Day, D. E., Zetoune, F. S., Sarma, J. V., Huber-Lang, M. S., & Ward, P. A. (2008) · The FASEB Journal · doi:10.1096/fj.08-110595 · Cited by 81
LU, Z. X., Fok, K. F., Erickson, B. W., & Hugli, T. E. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42796-7 · Cited by 76
Proctor, L. M., Arumugam, T. V., Shiels, I. A., Reid, R. C., Fairlie, D. P., & Taylor, S. M. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705819 · Cited by 76
Both C3a and C3adesArg Regulate Interleukin‐6 Synthesis in Human Peripheral Blood Mononuclear Cells
Takabayashi, T., Vannier, E. G., Burke, J. F., Tompkins, R. G., Gelfand, J. A., & Clark, B. D. (1998) · The Journal of Infectious Diseases · doi:10.1086/515316 · Cited by 69
Hollmann, T. J., Mueller‐Ortiz, S. L., Braun, M., et al. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.10.037 · Cited by 67
Serum complement levels and severity of sepsis.
Nakae, H., Endo, S., Inada, K., Takakuwa, T., Kasai, T., & Yoshida, M. (1994) · PubMed · Cited by 64
Cero, C., Vostrikov, V. V., Verardi, R., Severini, C., Gopinath, T., Braun, P. D., Sassano, M. F., Gurney, A., Roth, B. L., Vulchanova, L., et al. (2014) · Structure · doi:10.1016/j.str.2014.10.001 · Cited by 64
Langkabel, P., Zwirner, J., & Oppermann, M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199909)29:09<3035::aid-immu3035>3.0.co;2-z · Cited by 58
C3a expressed in the central nervous system protects against LPS-induced shock
Boos, L. A., Szalai, A. J., & Barnum, S. R. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.07.015 · Cited by 53
High Levels of Complement C3a Receptor in the Glomeruli in Lupus Nephritis
Mizuno, M., Blanchin, S., Gasque, P., Nishikawa, K., & Matsuo, S. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.02.271 · Cited by 48
Monsinjon, T., Gasque, P., Ischenko, A. M., & Fontaine, M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(00)02320-6 · Cited by 47
C3a receptor deficiency accelerates the onset of renal injury in the MRL/lpr mouse
Wenderfer, S. E., Wang, H., Ke, B., Wetsel, R. A., & Braun, M. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2008.12.004 · Cited by 45
Modulation of C3a Activity: Internalization of the Human C3a Receptor and its Inhibition by C5a
Settmacher, B., Bock, D., Saad, H., Gärtner, S., Rheinheimer, C., Köhl, J., Bautsch, W., & Klos, A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.12.7409 · Cited by 37
Lim, H., Kim, Y. U., Drouin, S. M., Mueller‐Ortiz, S. L., Yun, K., Morschl, É., Wetsel, R. A., & Chung, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052666 · Cited by 30
Kubota, Y. (1992) · The Journal of Dermatology · doi:10.1111/j.1346-8138.1992.tb03174.x · Cited by 24
Derivation of ligands for the complement C3a receptor from the C-terminus of C5a
Halai, R., Bellows, M. L., Branchett, W. J., Smadbeck, J. B., Kieslich, C. A., Croker, D. E., Cooper, M. A., Morikis, D., Woodruff, T. M., Floudas, C. A., et al. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.10.041 · Cited by 20
Self-citationComplement Activation Products C3a and C4a as Endogenous Antimicrobial Peptides
Zipfel, P. F., & Reuter, M. (2009) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-009-9180-5 · Cited by 20
Exogenous C3 Postpones Complement Exhaustion and Confers Organ Protection in Murine Sepsis
Yuan, Y., Ren, J., Wu, X., Cao, S., & Li, J. (2011) · Journal of Surgical Research · doi:10.1016/j.jss.2011.01.062 · Cited by 16
Cited by
Complement System Part I – Molecular Mechanisms of Activation and Regulation
Merle, N. S., Church, S. E., Fremeaux-Bacchi, V., & Roumenina, L. T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00262 · Cited by 1,620
Complement System Part II: Role in Immunity
Merle, N. S., Noe, R., Halbwachs-Mecarelli, L., Fremeaux-Bacchi, V., & Roumenina, L. T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00257 · Cited by 1,051
Lian, H., Litvinchuk, A., Chiang, A. C.-A., Aithmitti, N., Jankowsky, J. L., & Zheng, H. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.2117-15.2016 · Cited by 597
Neutrophil chemoattractant receptors in health and disease: Double-edged swords
Metzemaekers, M., Gouwy, M., & Proost, P. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0412-0 · Cited by 570
Complement in disease: a defence system turning offensive
Ricklin, D., Reis, E. S., & Lambris, J. D. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.70 · Cited by 550
Metadata
- Authors
- Coulthard, L. G., & Woodruff, T. M.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-04
- Volume
- 194
- Issue
- 8
- Pages
- 3542-3548
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1941186790
- Cited by
- 285
- References
- 60
- FWCI
- 10.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.